National Comprehensive Cancer Network



About NCCN

Neuroendocrine Tumors Panel - Disclosures as of 9/28/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Al B. Benson III, MD, FACP, FASCO

None

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Eli Lilly and Company;
General Electric;
Genomic Health, Inc.;
National Cancer Institute;
Onyx Pharmaceuticals, Inc.

None

None

9/25/2014

Emily Bergsland, MD

None

Novartis Pharmaceuticals Corporation

None

None

7/14/2014

Jordan D. Berlin, MD

None

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Enzon Pharmaceuticals;
Novartis Pharmaceuticals Corporation;
Roche Laboratories, Inc.

None

None

1/7/2014

Lawrence S. Blaszkowsky, MD

Genentech, Inc.;
GlaxoSmithKline

None

None

None

7/14/2014

Michael A. Choti, MD, MBA

None

Bristol-Myers Squibb Company;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

2/12/2013

Orlo H. Clark, MD

Xoma

Xoma

What Company?

None

3/8/2013

Gerard M. Doherty, MD

None

Novartis Pharmaceuticals Corporation

None

None

6/2/2011

Mary Dwyer, MS

None

None

None

None

10/9/2014

James Eason, MD

None

None

None

None

1/30/2012

Lyska Emerson, MD

None

None

None

None

9/16/2014

Paul F. Engstrom, MD, FACP

None

None

None

None

5/22/2014

Deborah Freedman-Cass, PhD

None

None

None

None

9/16/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

12/8/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Martin J. Heslin, MD

None

None

None

None

5/9/2014

Fouad Kandeel, MD, PhD

None

Molecular Insights Pharmaceuticals

None

None

7/3/2014

Anne Kessinger, MD

Pharmacyclics;
sanofi-aventis U.S.

None

None

None

5/4/2011

Matthew H. Kulke, MD

None

Novartis Pharmaceuticals Corporation;
Ipsen;
Lexicon;
Pfizer Inc.

None

None

9/16/2013

Pamela L. Kunz, MD

None

None

None

None

7/28/2014

Boris W. Kuvshinoff, MD, MBA

None

None

None

None

1/19/2014

Joan S. McClure, MS

None

None

None

None

12/8/2014

Jeffrey F. Moley, MD

None

None

None

None

10/3/2014

John A. Olson, MD, PhD

None

None

None

None

12/3/2009

Venu G. Pillarisetty, MD

None

None

None

None

1/16/2014

Leonard Saltz, MD

None

Abbott Laboratories;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Genzyme Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Asuragen, Inc.;
Roche Laboratories, Inc.;
YM BioScience Inc.

None

None

9/15/2013

Manisha H. Shah, MD

None

Novartis Pharmaceuticals Corporation

None

None

10/8/2014

Jonathan R. Strosberg, MD

Pfizer Inc.

Endo Pharmaceuticals

None

None

12/9/2013

Jean-Nicolas Vauthey, MD

None

None

None

None

6/27/2014

James C. Yao, MD

None

National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

12/9/2013